These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 19355804

  • 1. Impact of overactive bladder on work productivity in the United States: results from EpiLUTS.
    Sexton CC, Coyne KS, Vats V, Kopp ZS, Irwin DE, Wagner TH.
    Am J Manag Care; 2009 Mar; 15(4 Suppl):S98-S107. PubMed ID: 19355804
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Impact of overactive bladder on work productivity.
    Coyne KS, Sexton CC, Thompson CL, Clemens JQ, Chen CI, Bavendam T, Dmochowski R.
    Urology; 2012 Jul; 80(1):97-103. PubMed ID: 22748868
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Impact of urinary incontinence on healthcare resource utilization, health-related quality of life and productivity in patients with overactive bladder.
    Tang DH, Colayco DC, Khalaf KM, Piercy J, Patel V, Globe D, Ginsberg D.
    BJU Int; 2014 Mar; 113(3):484-91. PubMed ID: 24528881
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS.
    Coyne KS, Wein AJ, Tubaro A, Sexton CC, Thompson CL, Kopp ZS, Aiyer LP.
    BJU Int; 2009 Apr; 103 Suppl 3():4-11. PubMed ID: 19302497
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Racial differences in the prevalence of overactive bladder in the United States from the epidemiology of LUTS (EpiLUTS) study.
    Coyne KS, Margolis MK, Kopp ZS, Kaplan SA.
    Urology; 2012 Jan; 79(1):95-101. PubMed ID: 22055692
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS.
    Sexton CC, Coyne KS, Kopp ZS, Irwin DE, Milsom I, Aiyer LP, Tubaro A, Chapple CR, Wein AJ, EpiLUTS Team.
    BJU Int; 2009 Apr; 103 Suppl 3():12-23. PubMed ID: 19302498
    [Abstract] [Full Text] [Related]

  • 16. The impact of OAB on physical activity in the United States: results from OAB-POLL.
    Coyne KS, Sexton CC, Clemens JQ, Thompson CL, Chen CI, Bavendam T, Dmochowski R.
    Urology; 2013 Oct; 82(4):799-806. PubMed ID: 23953610
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women.
    Wennberg AL, Molander U, Fall M, Edlund C, Peeker R, Milsom I.
    Eur Urol; 2009 Apr; 55(4):783-91. PubMed ID: 19157689
    [Abstract] [Full Text] [Related]

  • 19. The prevalence of lower urinary tract symptoms (LUTS) and overactive bladder (OAB) by racial/ethnic group and age: results from OAB-POLL.
    Coyne KS, Sexton CC, Bell JA, Thompson CL, Dmochowski R, Bavendam T, Chen CI, Quentin Clemens J.
    Neurourol Urodyn; 2013 Mar; 32(3):230-7. PubMed ID: 22847394
    [Abstract] [Full Text] [Related]

  • 20. A population-based survey of lower urinary tract symptoms (LUTS) and symptom-specific bother: results from the Brazilian LUTS epidemiology study (BLUES).
    Moreira ED, Neves RC, Neto AF, Duarte FG, Moreira TL, Lobo CF, Glasser DB.
    World J Urol; 2013 Dec; 31(6):1451-8. PubMed ID: 23515960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.